Destiny Pharma is dedicated to the discovery, development and commercialisation of new anti-microbials that have unique properties to improve outcomes for patients and the delivery of medical care into the future.

Destiny Pharma’s vision is of an expanding range of anti-microbial drug products which operate within existing antibiotic markets but due to their unique features, open significant, new markets that are closed to traditional antibiotics due the existence or threat of antibiotic resistance.

Its proprietary, anti-microbial drug platform, the XF Drugs Series, act via an ultra-rapid action which kill bacteria (including antibiotic resistant strains) leaving the bacteria unable to mount a resistance response.